Concomitant 5-fu, hydroxyurea and cisplatin with external beam radiation therapy for locally advanced pancreatic cancer: A phase II study

Oncology Reports

Volumn 4, Issue 5, 1997, Pages 877-881

  Chen, Luci M ^a   Haraf, Daniel ^a   Brachman, David G ^a   Vokes, Everett E ^a   Schilsky, Richard L ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Chemoradiotherapy; Pancreas cancer

Indexed keywords

CISPLATIN; FLUOROURACIL; HYDROXYUREA;

ADULT; AGED; ANEMIA; ANOREXIA; ARTICLE; BEAM THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DRUG EFFICACY; FEMALE; HEARING LOSS; HUMAN; MALE; MUCOSA INFLAMMATION; NAUSEA; NEUTROPENIA; PANCREAS ADENOCARCINOMA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; SEIZURE; THROMBOCYTOPENIA; VOMITING;

EID: 0030849950     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Tepper J, Nardi G, Suit H, et al: Carcinoma of the pancreas: review of MGH experience from 1963-1973. Cancer 37: 1519-1524, 1976.
2. Gastrointestinal Tumor Study Group: Comparative therapeutic trial of radiation with or without chemotherapy in:pancreatic carcinoma. Int J Radiat Oncol Biol Phys 5: 1643-1647, 1979.
3. Gastrointestinal Tumor Study Group: Radiation therapy combined with adriamycin or 5-Fluorouracil for the treatment of locally unresectable pancreatic carcinoma. Cancer 56: 2563-2568, 1985.
4. Gastrointestinal Tumor Study Group: Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. J Natl Cancer Inst 80: 751-755, 1988.
5. Cameron J, Crist D, Yeo C, et al: One hundred and forty-five consecutive pancreaticoduodenectomies without mortality. Ann Surg 217: 430-438, 1993.
6. Gastrointestinal Tumor Study Group: Phase II studies of drug combinations in advanced pancreatic carcinoma: fluorouracil plus doxorubicin plus mitomycin C and two regimens of streptozotocin plus mitomycin C plus fluorouracil. J Clin Oncol 4: 1794-1798, 1986.
7. Wingo P, Tong T and Bolden S: Cancer Statistics, 1995. CA - A Cancer J Clin 45: 8-30, 1995.
8. Griffin J, Smalley S, Jewell W, et al: Patterns of failure following curative resection of pancreatic carcinoma. Cancer 66: 56-61, 1990.
9. Oster M, Gray R, Panasci L, et al: Chemotherapy for advanced pancreatic cancer: a comparison of 5-Fluorouracil, Adriamycin, and Mitomycin (FAM) with 5-Fluorouracil, Streptozotocin, and Mitomycin (FSM). Cancer 57: 29-33, 1986.
10. Moertel C, Frytak S, Hahn R, et al: Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose (4000 rads + 5-Fluorouracil), and high dose radiation plus 5-Fluorouracil. Cancer 48: 1705-1710, 1981.
11. Whittington R, Dobelbower R, Mohuiddin M, et al: Radiotherapy of unresectable pancreatic carcinoma: a six year experience with 104 patients. Int J Radiat Oncol Biol Phys 7: 1639-1644, 1981.
12. Gastrointestinal Tumor Study Group: Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer 59: 2006-2010, 1987.
13. Kalser M and Ellenberg S: Pancreatic cancer: adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 120: 899-903, 1985.
14. Vokes E, Panje W, Schilsky R, et al: Hydroxyurea, Fluorouracil, and concomitant radiotherapy in poor-prognosis head and neck cancer: a phase I-II study. J Clin Oncol 7: 761-768, 1989.
15. Vokes E: Concomitant chemoradiotherapy as investigational therapy for locoregionally advanced head and neck cancer. Frontiers Radiat Ther Oncol 26: 55-63, 1992.
16. Haraf D, Vokes E, Weichselbaum R, et al: Concomitant chemoradiotherapy with cisplatin, 5-fluorouracil, and hydroxyurea in poor-prognosis head and neck cancer. Laryngoscope 102: 630-636, 1992.
17. Connolly M, Dawson P, Michelassi F, et al: Survival in 1001 patients with carcinoma of the pancreas. Ann Surg 206: 366-373, 1987.
18. Vokes E, Kies M, Haraf D, et al: Induction chemotherapy followed by concomitant chemoradiotherapy for advanced head and neck cancer: impact on the natural history of the disease. J Clin Oncol 13: 876-883, 1995.
19. Vokes E, Weichselbaum R, Mick R, et al: Favorable long-term survival following induction chemotherapy with ciplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer. J Natl Cancer Inst 84: 877-882, 1992.
20. Vokes E, Haraf D, Panje W, et al: Hydroxyurea with concomitant radiotherapy for locally advanced head and neck cancer. Semin Oncol 19: 53-58, 1992.
21. Whittington R, Solin L, Mohuiddin M et al: Multimodality therapy of localized unresectable pancreatic adenocarcinoma. Cancer 54: 1991-1998, 1984.
22. Roldan G, Gunderson L, Nagorney DM, et al: External beam versus intraoperative and external beam irradiation for locally advanced pancreatic cancer. Cancer 61: 1110-1116, 1988.
23. Seydel HG, Stablein DM, Leichman LP, et al: Hyperfractionated radiation and chemotherapy for unresectable localized adenocarcinoma of the pancreas. Cancer 65: 1478-1482, 1990.
24. Klaassen DJ, MacIntyre JM, Catton GE, et al: Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil - An Eastern Cooperative Oncology Group Study. J Clin Oncol 3: 373-378, 1985.
25. Zerbi A, Fossati V, Parolini D, et al: Intraoperative radiation therapy adjuvant to resection in the treatment of pancreatic cancer. Cancer 73: 2930-2935, 1994.
26. Tepper J, Noyes D, Krall J, et al: Intraoperative radiation therapy of pancreatic carcinoma: a report of RTOG-8505. Int J Radiat Oncol Biol Phys 21: 1145-1149, 1991.
27. Mohuiddin M, Rosato F, Barbot D, et al: Long-term results of combined modality treatment with I-125 implantation for carcinoma of the pancreas. Int J Radiat Oncol Biol Phys 23: 305-311, 1992.
28. Cullinan S, Moertel C, Fleming T, et al: A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin. J Amer Med Assoc 253: 2061-2067, 1985.
29. Taylor O, Benson E, McMahon M, et al: Clinical trial of tamoxifen in patients with irresectable pancreatic adenocarcinoma. Br J Surg 80: 384-386, 1993.
30. Casper E, Green M, Kelsen D, et al: Phase II trial of gemcitabine (2,2′-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas. Invest New Drugs 12: 29-34, 1994.
31. Schnall S and Macdonald J: Chemotherapy of adenocarcinoma of the pancreas. Semin Oncol 23: 220-228, 1996.
32. Foo M, Gunderson L, Nagorney D, et al: Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation +/- 5 fluorouracil. Int J Radiat Oncol Biol Phys 26: 483-489, 1993.
33. Higgins P, Sohn J, Fine R, et al: Three-dimensional conformal pancreas treatment: comparison of four- to six-field techniques. Int J Radiat Oncol Biol Phys 31: 605-609, 1995.